| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.0063 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |